Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery (DARE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck
Information provided by (Responsible Party):
F Holleman, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ClinicalTrials.gov Identifier:
NCT01272583
First received: January 5, 2011
Last updated: March 7, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)